Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $1.26 billion. The enterprise value is $1.68 billion.
| Market Cap | 1.26B |
| Enterprise Value | 1.68B |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 46.50 million shares outstanding. The number of shares has decreased by -5.10% in one year.
| Current Share Class | 46.50M |
| Shares Outstanding | 46.50M |
| Shares Change (YoY) | -5.10% |
| Shares Change (QoQ) | -3.53% |
| Owned by Insiders (%) | 9.28% |
| Owned by Institutions (%) | 71.24% |
| Float | 35.35M |
Valuation Ratios
The trailing PE ratio is 10.08 and the forward PE ratio is 8.07. AMPH's PEG ratio is 31.24.
| PE Ratio | 10.08 |
| Forward PE | 8.07 |
| PS Ratio | 1.79 |
| Forward PS | 1.66 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 7.01 |
| P/FCF Ratio | 11.19 |
| P/OCF Ratio | 7.86 |
| PEG Ratio | 31.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.09, with an EV/FCF ratio of 14.97.
| EV / Earnings | 12.46 |
| EV / Sales | 2.32 |
| EV / EBITDA | 7.09 |
| EV / EBIT | 9.24 |
| EV / FCF | 14.97 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.87.
| Current Ratio | 3.29 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 2.69 |
| Debt / FCF | 5.84 |
| Interest Coverage | 5.70 |
Financial Efficiency
Return on equity (ROE) is 18.32% and return on invested capital (ROIC) is 8.27%.
| Return on Equity (ROE) | 18.32% |
| Return on Assets (ROA) | 7.31% |
| Return on Invested Capital (ROIC) | 8.27% |
| Return on Capital Employed (ROCE) | 12.63% |
| Revenue Per Employee | $356,351 |
| Profits Per Employee | $66,424 |
| Employee Count | 2,028 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.31 |
Taxes
In the past 12 months, AMPH has paid $27.13 million in taxes.
| Income Tax | 27.13M |
| Effective Tax Rate | 16.77% |
Stock Price Statistics
The stock price has decreased by -43.86% in the last 52 weeks. The beta is 0.80, so AMPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -43.86% |
| 50-Day Moving Average | 25.77 |
| 200-Day Moving Average | 29.19 |
| Relative Strength Index (RSI) | 41.92 |
| Average Volume (20 Days) | 415,332 |
Short Selling Information
The latest short interest is 4.16 million, so 8.94% of the outstanding shares have been sold short.
| Short Interest | 4.16M |
| Short Previous Month | 4.13M |
| Short % of Shares Out | 8.94% |
| Short % of Float | 11.76% |
| Short Ratio (days to cover) | 6.99 |
Income Statement
In the last 12 months, AMPH had revenue of $722.68 million and earned $134.71 million in profits. Earnings per share was $2.68.
| Revenue | 722.68M |
| Gross Profit | 360.33M |
| Operating Income | 181.67M |
| Pretax Income | 201.63M |
| Net Income | 134.71M |
| EBITDA | 236.73M |
| EBIT | 181.67M |
| Earnings Per Share (EPS) | $2.68 |
Balance Sheet
The company has $231.75 million in cash and $655.50 million in debt, giving a net cash position of -$423.75 million or -$9.11 per share.
| Cash & Cash Equivalents | 231.75M |
| Total Debt | 655.50M |
| Net Cash | -423.75M |
| Net Cash Per Share | -$9.11 |
| Equity (Book Value) | 757.48M |
| Book Value Per Share | 16.29 |
| Working Capital | 404.42M |
Cash Flow
In the last 12 months, operating cash flow was $159.66 million and capital expenditures -$47.47 million, giving a free cash flow of $112.19 million.
| Operating Cash Flow | 159.66M |
| Capital Expenditures | -47.47M |
| Free Cash Flow | 112.19M |
| FCF Per Share | $2.41 |
Margins
Gross margin is 49.86%, with operating and profit margins of 25.14% and 18.64%.
| Gross Margin | 49.86% |
| Operating Margin | 25.14% |
| Pretax Margin | 22.39% |
| Profit Margin | 18.64% |
| EBITDA Margin | 32.76% |
| EBIT Margin | 25.14% |
| FCF Margin | 15.52% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.10% |
| Shareholder Yield | 5.10% |
| Earnings Yield | 10.73% |
| FCF Yield | 8.94% |
Analyst Forecast
The average price target for AMPH is $35.50, which is 31.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $35.50 |
| Price Target Difference | 31.48% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 4.68% |
| EPS Growth Forecast (5Y) | 5.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.9 |
| Piotroski F-Score | 4 |